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Localization and characterization of renal calcitonin receptors by in
vitro autoradiography. Calcitonin receptor binding sites were identified
in renal cortex and medulla using the radioligand '251-salmon calcitonin.
Microscopic localization of these receptors revealed binding over
meduilary and cortical thick ascending limb of the loop of Henle and in
distal convoluted tubule. A number of receptor positive cells in the
inner medulla were also identified. Characterization of the binding
demonstrated a single class of high-affinity binding sites in both the
medulla and the cortex with affinity constants of 0.74 0.09 X iOM1
and 0.32 0.05 x l0 M1, respectively, and receptor concentrations of
205 45 fmollmg protein and 453 54 fmol/mg protein, respectively.
Competition for '251-salmon calcitonin binding by a wide range of
calcitonin analogs revealed a close correspondence between the re-
ported biological potencies and activities in the current system. The
localization of binding sites within the nephron corresponds to the
reported localization of calcitonin-stimulated adenylate cyclase activity
and suggests that the receptor mediated actions of calcitonin in the
kidney utilize cyclic AMP as a second messenger. In addition, the
microscopic identification of specific calcitonin receptors helps the
delineation of direct actions of this hormone from those which are
indirect.
Calcitonin (CT) is one of the major calcitropic hormones with
its primary effect of inhibiting bone resorption by acting on the
osteoclast where abundant receptors for calcitonin have been
identified [I]. In the kidney, calcitonin affects the handling of
Mg2, P042, Ca and Na [2—91, and is also reported to
influence the metabolism of Vitamin D in this organ [10, 11].
Receptors for CT have been identified in renal plasma mem-
branes [12] and in cultured kidney cells [13]. In addition, the
calcitonin-sensitive adenylate cyclase in the nephron has been
well characterized [14]. However, it has been suggested that
calcitonin may act independently of adenylate cyclase to influ-
ence the metabolism of Vitamin D in the proximal tubule [10,
11].
Recently, CT binding sites in both the cortex and outer
medulla have been identified [15], although without detailed
microscopic localization. In vivo autoradiographic studies have
localized specific cortical binding sites to distal convoluted
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tubule [16]; however, this technique is subject to problems with
tracer degradation, sensitivity and high non-specific binding.
Characterization of binding is also severely restricted with this
technique.
Using the technique of in vitro autoradiograph we have,
therefore, further localized 1251-SCT binding to tubular seg-
ments within the nephron. We have also performed a regional
quantitative analysis of binding densities and affinities. These
binding sites have been characterized in different regions using
a wide range of analogs in order to assess their relation to
biologically functional receptors.
Methods
Materials
Salmon calcitonin (SCT), des Leu'6 SCT, Gly8 SCT, des Ser2
Glyt SCT, des Ser2 des Tyr22 SCT, human calcitonin (HCT),
des Ser2 Gly8 des Tyr22 SCT, G1y8 des Tyr22 SCT, des Phe'6
HCT, G1y8 HCT, and porcine calcitonin (PCT), were supplied
by Dr. R. C. Orlowski (Armour Pharmaceutical Co. Kankakee,
Illinois, USA) and eel calcitonin (ELTN 2003) (ECT) by Dr. J.
Murase (Toyo Jozo company, Shizouka, Japan). The other
hormones were obtained from the following sources: parathy-
roid hormone (PTH), Beckman Pty. Ltd., Palo Alto, California,
USA; human growth hormone (HGH), Dr. P. J. Lowry, St.
Bartholemew's Hospital, London, UK; human calcitonin gene-
related peptide (HCGRP), Bachem, California, USA; bovine
luteinizing hormone (LH), Prof. H.G. Burger, Prince Henry's
Hospital, Melbourne, Australia; adrenocorticotrophic hormone
(ACTH), Ciba Geigy, Basle, Switzerland.
SCT was labelled with 1251 as previously described to pre-
serve biological activity [17, 18], using 1 g chloramine T for 10
seconds and purification with QUSO G32, elution and storage at
—20°C in 20% acetone- 1% acetic acid. Specific activities
ranged from 150 to 200 CiIg.
Autoradiography
Receptor characterization by dry film autoradiography. Ten,
male Sprague-Dawley rats (250 to 300 g) were decapitated, their
kidneys rapidly removed and frozen for 10 to 20 seconds by
immersion in isopentane at —40°C. Serial 20 sm horizontal
sections, around the midline, were cut on a cryostat at —20°C,
thaw mounted onto gelatine coated slides, dehydrated at re-
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duced pressure in a dessicator at 4°C for two to four hours and
stored at —70°C in sealed boxes containing silica gel until use
[191.
Each kidney was serially sectioned to provide sections for the
analysis of one analog curve plus an unlabelled SCT competi-
tion curve as a control.
The sections were preincubated for 15 minutes in 50 mrvi Tris
HC1 buffer, pH 7.4, containing 100 m'vi NaC1, 0.2% bovine
serum albumin and 0.4 mri bacitracin at 20°C, and then incu-
bated for one hour in 5 ml of the same buffer containing
'251-SCT (82 pM) and increasing concentrations of the unla-
belled peptides (10—" — 3 x 10rO. The slide mounted
sections were then rapidly washed using four, one minute
transfers through 50 mrvx Tris HC1, pH 7.4, containing 100 mM
NaCl at 0°C and dried in a stream of cold air.
The dried sections were exposed to Agfascopix CR3B (Agfa
Gevaert, Belgium) x-ray film for 7 to 21 days in x-ray cassettes.
A set of radioactivity standards were included in each cas-
sette [201. This enabled remapping of optical densities of each
pixel in the digitized autoradiograph in terms of dpmlmm2 using
a computer-constructed calibration curve. Protein content of
kidney regions was measured in 20 m sections of cortex, outer
medulla and inner medulla which were digested in 1 M NaOH for
protein estimation [21]. Areas were measured on adjacent
sections using the image processor. These values enabelled
direct conversion of radioligand density in dpm/mm2 into units
of fmollmg protein. The x-ray films were processed in a Kodak
RP-xomat automatic developer (Eastman Kodak, Rochester,
New York, USA).
The autoradiographs were analyzed with an EyeCom Model
850 image processor (Log E/Spatial Data systems, Springfield,
Virginia, USA), coupled to a DEC 11/23 LSI computer to obtain
color-coded images calibrated in terms of radioligand density.
To test whether tracer degradation was a factor in these
experiments, we have performed rebinding studies. This in-
volved incubation of kidney sections with '251-SCT as described
above; the sections were removed and the incubation buffer
used in a second incubation with fresh sections. Binding (BIT)
in the initial incubation was 9.97 0.12 x 10'% (N = 5), and
in the rebinding incubation was 9.23 0.03 x 10'% (N = 5).
Also, the patterns of distribution of total and non-specific
binding were identical in the two sets. The ratios of non-specific
to total binding in the first and second incubations were 9.0%
and 8.6%, respectively. These results indicate that the radioli-
gand was not degraded during incubation.
Binding isotherms were analyzed by a non-linear, iterative,
model-fitting computer program [22]. Results are expressed as
final parameter estimates standard error of the mean.
Analysis of the autoradiographs and binding isotherms were
performed blind to exclude subjective bias in the results.
Light microscopic localization of receptors. Three hundred
to 500 m midline transverse sections of fresh kidney were cut
on a vibratome and pre-incubated and incubated as described
above. Non-specific binding was determined in the presence of
1 M unlabelled SCT. Following incubation the sections were
washed using 4 x two minute transfers through 50 msi Tris HC1
pH 7.4, 100 mrs NaCl at 0°C, then fixed in 2.5% gluteraldehyde
at 4°C overnight. The tissues were embedded in paraffin,
sectioned at 3 pm and mounted on clean glass slides. After
drying the sections were defatted/deparaffinized and processed
for emulsion autoradiography as follows:
The sections were dipped for 1 to 2 seconds in a 1:1 dilution
of Kodak NTB2 emulsion with distilled water at 43°C, gelled on
ice for 10 minutes, then dried for two hours at 25°C, > 80% RH.
The sections were stored at —20°C in sealed boxes with
dessicant for five to eight days, when they were developed for
two minutes with Kodak D19 developer at 17°C. Following
development the sections were stained with hematoxylin and
eosin to enable localization of grain densities.
Results
Receptor characterization
Binding of '251-SCT to rat kidney sections was saturable and
reached equilibrium by 60 minutes. Non-specific binding, mea-
sured in the presence of 10—6 M SCT was less than 10% of the
total binding (Fig. 1).
Analysis of the competition for '251-SCT binding in both
medulla and cortex of the kidney by unlabelled SCT revealed a
single class of sites for each region, with affinity constants of
respectively 0.74 0.09 x i0 M1 and 0.32 0.05 x i09 M1,
and binding site concentrations of 205 45 fmollmg protein and
453 54 fmol/mg protein, respectively (Fig. 2).
A range of 16 calcitonin analogs and other peptides were
evaluated for potency in competing with '251-SCT in this
system. ECT, des Ser2 des Tyr22 SCT and des Ser2 Gly8 SCT
were potent in competing with '251-SCT with affinity constants
similar to or greater than that of unlabelled SCT in both the
medulla (Table 1, Fig. 3) and cortex (Table 2, Fig. 4). PCT, Gly8
SCT, 01y8 des Tyr22 SCT and des Ser2 G1y8 des Tyr22 were
between 1/5 and 1/10 the potency of SCT, while the human
calcitonins had only low potency in competing with the labelled
peptide. (Table 1, Fig. 3 medulla, Table 2, Fig. 4 cortex).
There was a strong correlation between the relative potencies
of the calcitonin analogs in competing for binding in the cortex
and medulla (r = 0.99, P < 0.01).
The biologically unrelated peptides ACTH, LH, HGH and
HCGRP did not compete for binding with concentrations of up
to 3 x l06M.
Localization of receptors
Macroscopic localization of '251-SCT receptor binding using
dry film autoradiography revealed a high density of binding over
the cortex and the inner stripe of the outer medulla, with
intermittent patches of binding linking the medullary binding to
that of the cortex (Fig. IA).
Analysis of the macroscopic localization of receptor binding
using light microscopic emulsion autoradiography showed that
grain densities in the inner stripe of the outer medulla were
confined to the thick ascending limb of the loop of Henle (Fig.
SC, D). The medullary collecting tubules were free of binding
(Fig. SC) as was the thin limb of the loop of Henle (Fig. SD).
The intermittent patches of binding seen in the outer stripe of
the outer medulla reflected binding to the thick ascending limb
of the loop of Henle.
In the cortex, grain densities were found overlying the distal
convoluted tubules (Fig. SA, B, F) including early distal tubule
(Fig. SA) and appeared to follow the transition of the thick
ascending limb of the loop of Henle to distal tubule. Binding
'N
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was absent over proximal tubule (Fig. SA, B) and glomeruli
(Fig. SA).
Due to difficulty in differentiating early cortical collecting
tubule from distal tubule, it was unclear whether this segment of
the nephron possessed receptors for calcitonin. However, there
were collecting tubules in the cortex which did not have
detectable binding (not shown). In the inner medulla receptors
were found over a number of isolated cells which generally
appeared distinct from both collecting tubules and the thin
loops of Henle (Fig. SE, arrowed). Receptor binding was absent
from the inner medullary collecting tubules (Fig. SE) and the
thin loop of Henle found in the region (Fig. SE), and from blood
vessels throughout the kidney (Fig. SB, F).
Binding over tubular segments was undetectable in the pres-
ence of 10-6 unlabelled SCT.
Fig. 1. Autoradiographic localization of
'251..SCT binding. A. Total binding. B. Non
specific binding. Abbreviations are: Cx,
cortex; IM, inner medula; OM(I), inner stripe
of the outer medulla; OM(O) outer stripe of
the outer medulla. (x8)
Discussion
In these studies we have identified and localized high affinity,
high-specificity binding sites for '251-salmon calcitonin. The
characterization of these binding sites in both medullary and
cortical regions of the kidney revealed binding potencies of
calcitonin analogs which closely paralleled their biological
activity [23—28]. This strongly suggests that the binding sites
identified in this study represent the recognition site of the
calcitonin receptor.
The relative potencies of the CT's and analogs was similar
between medullary and cortical regions, although the medullary
receptors (associated with thick ascending limb of the loop of
Henle) appeared to have slightly higher affinity than the cortical
receptors (primarily associated with distal tubule). Despite the
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Fig. 2. Binding isotherms of competition of '251-SCT binding to rat
kidney by unlabelled SCT. Symbols are (•) medulla; (0) cortex.
overall similarity in analog potency with cell preparations, there
exists a discrepancy between the potency of some of the SCT
analogs in our preparation and their potency in competing for
'251scT binding and stimulating adenylate cyclase in the T47D,
human breast cancer cell-line [23]. In the latter experiments
[23], it was found that deletion of Ser2 and Tyr22 and substitu-
tion of glycine at position 8 individually or in combination did
not affect the potency of these analogs. In our experiments on
rat kidney sections, however, Gly8 SCT, des Ser2 G1y8 des Tyr22
SCT, and Glyt des Tyr22 SCT had lower potencies at the
receptor.
The nature of this discrepancy is not clear, although it may
reflect differences in the binding of live cells and that of tissue
slices, or alternatively it may reflect some difference in the
susceptibility of these analogs to degradation by renal enzymes.
We have shown previously that rat kidney has a potent ability
to degrade salmon and other calcitonins [29].
The current macroscopic localization of receptors is similar
Table 1. Relative potencies of calcitonins and their analogs in
competing with '251.SCT binding to rat kidney sections (medulla)
Potency
Hormone or analog KAa/KAC
HCT 0.005
PCT 0.2
SCT (25R) 0.9
ECT (ELTN 2003) 1.5
des Le&6 SCT 0.01
Gly8 SCT 0.15
des Ser2 G1y8 des Tyr22 SCT 0.14
des Ser2 des Tyr22 SCT 1.7
des Ser2 G1y8 SCT 1.6
G1y8 des Tyr22 SCT 0.16
des Ph&6 HCT 0.0008
G1y8 HCT <0.0001
Potencies are expressed as a ratio of the affinity constant of the
analog (KAa) to the affinity constant from a control SCT competition
analysis (KA).
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outer medulla by unlabelled calcitonin analogs.
to that recently published by Bouizar and colleagues [15] who
identified both cortical and medullary regions rich in binding
sites for CT. However, we did not find, macroscopically, the
binding in the inner medulla which they attribute to the ascend-
ing thin limb of the loop of Henle. Similarly, this is inconsistent
.0
ACTH
LH
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Table 2. Relative potencies of calcitonins and analogs in competition
with '251-SCT binding to rat kidney sections (cortex)
Potency
Hormone or analog KAa/KAC
0.005
with the localization of CT-sensitive adenylate cyclase which
was absent in the thin loop of Henle [14].
Microscopically, the localization of binding over distal con-
voluted tubule confirms the in vivo autoradiographic evidence
which demonstrated association of CT binding sites with the
basolateral membrane of distal tubule [16]. The current local-
ization of grains over cytoplasmic regions of the cell as well as
basolateral membrane (Fig, 5A, B, F) is likely to be due to the
larger section thickness used in the present study as well as the
numerous infoldings of this membrane. In the present study, we
also identified the thick ascending limb of the loop of Henle as
the component responsible for binding to the outer medulla and
inner cortex. The resolution of the technique also enabled the
identification of individual, CT receptor-positive cells in the
inner medulla which did not appear to be associated with either
collecting tubules or the ascending thin limb of the loop of
Henle. These cells probably correspond to medullary interstitial
cells although binding to an atypical collecting duct cell cannot
be ruled out. These cells represent a previously unknown site of
action for CT in the kidney.
Morel, Imbert-Teboul and Chabards [14], using microdis-
sected tubules have identified the calcitonin-sensitive, adenyl-
ate cyclase-responsive regions throughout the nephron. Their
work identified medullary and cortical thick ascending limbs of
the loop of Henle, distal tubule and cortical collecting tubule as
the adenylate cyclase-responsive segments. Similarly, our work
has demonstrated the presence of calcitonin receptors through-
out these segments, but not in regions where calcitonin failed to
stimulate adenylate cyclase. This suggests that, in the kidney,
calcitonin-specific receptors utilize cAMP as their second mes-
senger.
Our data suggests that the reported action of CT in stimulat-
ing 1 a-hydroxyation of Vitamin D in the proximal straight
tubule of the rat [101 is due to an indirect action of calcitonin
rather than a direct effect through its specific receptor, since
this region of the nephron lacks CT receptors.
In terms of the physiology of the interaction between CT and
the kidney, the presence of receptors for CT in the thick limb of
Henle's loop correlates with the reported action of CT on
fractional excretion of Ca2 and Mg2 in this segment of the
nephron [2, 6, 7]. Various investigators have reported a marked
phosphaturia in response to CT in the rat [3, 8, 30], while others
do not detect a phosphaturic response [6]. Under conditions
designed to elicit a phosphaturic response with calcitonin,
Berndt and Knox [3] localized the primary site of action to the
proximal convoluted tubule. Lack of specific receptors for CT
in this segment of the nephron, as demonstrated in this paper,
suggest that this effect is due to an indirect action of the
hormone. In support of this assertion is the apparent require-
ment of high "pharmacological" doses of the hormone to elicit
the response [2, 3, 8, 30], while the effects on Mg2 and Ca2
can be induced with moderate concentrations of SCT [2]. A less
obvious, but more likely action for calcitonin in the distal tubule
is in reduction of potassium secretion [9], and possibly, in the
early cortical collecting duct in water reabsorption [14].
While the physiological role of CT in the kidney remains
unclear, the microscopic localization of specific receptors for
CT helps to delineate between direct actions of the hormone,
which appear to be associated with adenylate cyclase, and
those which are indirect, In addition, the identification of CT
receptors associated with isolated cells in the inner medulla
suggests the possibility of unexpected actions of the hormone at
this site.
ACTH
LH
HGH
HCGRP
HCT
PCT 0,14
SCT (25R) 1.3
ECT (ELTN 2003) 3.2
des Leu'6 SCT 0.01
G1y8 SCT 0.21
des Ser2 Gly8 des Tyr22 SCT 0.12
des Ser2 des Tyr22 SCT 1.5
des Ser2 G1y8 SCT 0.9
G1y8 des Tyr22 SCT 0.1
des Phe'6 HCT 0.0004
G1y8 HCT <0.0001
Potencies are expressed as a ratio of the affinity constant of the
analog (KAa) to the affinity constant from a control SCT competition
analysis (KAç).
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Fig. 4. Binding isotherms of competition for t2SISCT binding to renal
cortex by unlabelled calcitonin analogs.
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Fig. 5. Light microscopic autoradiographic localization of SCT binding to rat kidney. Abbreviations are: by, blood vessels; CT, collecting tubule;
DCT, distal convoluted tubule; G, glomerulus; PCT, proximal convoluted tubule; TAL thick ascending limb of Henle's loop; TL, thin limb of
Henle's loop. (xllOO)
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